Skip to main content

Site notifications

Guideline on immunogenicity assessment of biotechnology-derived therapeutic proteins

We have adopted this International Scientific Guideline - EMEA/CHMP/BMWP/14327/2006.

Last updated

Help us improve the Therapeutic Goods Administration site